3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other neoplasm
1
Breast
1
Conditions
Breast Neoplasms
157
Carcinoma, Intraductal, Noninfiltrating
16
Breast Carcinoma In Situ
12
Neoplasm Metastasis
9
Ovarian Neoplasms
7
Breast Neoplasms, Male
7
Neoplasms
4
Prostatic Neoplasms
3
Inflammatory Breast Neoplasms
3
Glioblastoma
3
Breast Cancer Female
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Obesity
2
Infertility
2
Hot Flashes
2
Fibroadenoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
ER+ Breast Cancer
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Sexuality
1
Risk Reduction Behavior
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Primary Breast Cancer
1
Interventions
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
fludarabine phosphate
5
Immunohistochemistry
5
Epoetin Alfa
5
Cyclophosphamide
5
Tacrolimus
4
Methotrexate
4
Gene Expression Profiling
4
Celecoxib
4
Mycophenolic Acid
3
Microarray Analysis
3
Imiquimod
3
Etoposide
3
Darbepoetin alfa
3
Cyclosporine
3
Colposcopy
3
Busulfan
3
Antilymphocyte Serum
3
Aminolevulinic Acid
3
Tomography, Optical Coherence
2
Sirolimus
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Melphalan
2
Mass Spectrometry
2
Immunoenzyme Techniques
2
Filgrastim
2
Fatty Acids, Omega-3
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Precancerous Conditions
×
Tamoxifen
×
Clear all
NCT06982313
2026-03-11
Babytam long
Ente Ospedaliero Ospedali Galliera
Completed
1,545 enrolled